Search

  1. ProQR to Present at Upcoming Scientific and Industry Conferences

    Press release

    … company dedicated to changing lives through transformative RNA therapies, today announced several presentations … highlighting the Company’s proprietary Axiomer ® RNA editing technology platform at upcoming scientific and … 2023, in Basel, Switzerland; and the bi-annual RNA Editing Gordon Research Conference (GRC), March 19-24, 2023 in …

  2. ProQR Announces First Quarter 2025 Operating and Financial Results

    Press release

    Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened leadership with appointments of Chief Financial Officer and Chief

  3. ProQR Announces First Quarter 2023 Operating and Financial Results

    Press release

    Initial pipeline programs with liver delivery to address Cholestatic Diseases targeting NTCP and Cardiovascular Disease targeting B4GALT1 Development of Axiomer® RNA base editing technology platform continues across multiple therapeutic areas Stre